UCSF

Tagged: Chemistry and Chemical Biology Graduate Program (CCB)

Gartner to co-direct new UCSF-based Center for Cellular Construction

UCSF School of Pharmacy faculty member Zev Gartner, PhD, will be co-director of a new multi-institution UCSF-administered Center for Cellular Construction, which has been awarded a five-year $24 million grant by the National Science Foundation (NSF).

Celebrating the 100th birthday of Edward Leong Way

Edward (Eddie) Leong Way, BS, MS, PhD, celebrated his 100th birthday on July 1, 2016, with more than 70 colleagues, friends, and family at the UCSF Mission Bay Conference Center.

Research: pediatric meningitis dosing; cancer drug resistance; gene-testing economics

Computer models provide optimal dosing for pediatric TB meningitis

Study identifies eye-drop-soluble compound that could treat cataracts

Cataracts are the leading cause of blindness worldwide, the leading cause of vision loss in the United States, and cases are increasing with an aging population. Currently the condition can be treated with surgery—an expensive intervention that leaves most patients blinded in developing countries...

Shoichet study sheds light on “dark” cell receptors, potential drug targets

More than a quarter of all drugs work by targeting one of a large family of proteins called G-protein-coupled receptors (GPCRs). Hundreds of different GPCRs are embedded in cell membranes, converting stimuli from the outside world—neurotransmitters, hormones, even light—into intracellular signals...

Update from the Dean - Fall/Winter 2015

Strategic planning; Recently received research funding: cancer, Alzheimer's, HIV, type 2 diabetes (Kroetz, Keiser, Gross, Roy); Recent faculty publications: fibrosis, biofilms, gout (DeGrado, Yang, Giacomini); Collaborations and partnerships; Patient care: SB 493, scope of practice for California...

Desai elected to the National Academy of Medicine

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

Fischbach joins project to generate drugs from bacterial genomes

Bacteria generate small molecules to fend off their fellow microbes. They also produce molecules that affect the response of host organisms—including humans—to their presence. Such molecules have been a major source of antibiotics, immunosuppressants, anti-cancer agents, and other drugs.

Pages